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Int roduction
Carbamazepine has been proven to be efficacious in some pati ent s with affective disorders, notably those who have not responded well to lithium ca rbona te or neuro leptics (1,2,3) . For those who have responded poorly to either regimen, however, there have been no effective pharmacotherapies until recently, when case reports have suggested a possible synergistic action between lithium carbonat e a nd carba mazepine (4, 5, 6) . The following case report supports this hypothesis.
Case Report
A 43-year-old man diagnosed by DSM-III criteria as having a bipola r disorder, manic type , was admitted to a psychiatric hospital, Coatesville VA Medical Center, for the fourth time in two years . Admission physical and laboratory results, as well as a n EEG, were unremarkable. During previous admissions, thi s pati ent had remained unimproved despite adequate trials of a combination of lithium carbonate at plasma levels of 1.0-1 .5 mliq / Iiter and high doses of various classes of neuroleptics. Aga in, on this admission, the patient was unc hanged despite high doses of neuroleptics, includ ing chlorpromazine at up to 2000 mg.j'day, and lithium carbonate a t levels of 0.9-1.5 rnliq / Iiter. On day eighteen carbamazepine was begun. Wihin four days th e pa tient displayed mar ked reduction of psychomotor agitation, aggressiveness, and irritab ility, and on the twenty-second hospital day his ch lorpromazine was discontinued. H is improveme nt contin ued with abatement of manic symptoms. On the fifty-seventh hospital day, lithium carbonate was stopped to evalu ate the patient 's reponse to carbamazepine alone. His carbamazepine level, which ranged from 4.6-6. 7 ugj ml (therapeutic range for seizure disorde rs: 3-12 ug / rnl), was then 6.7 ug/ rnl. The pat ient displayed a gra dual rec ru descence of manic symptoms, including violent threat s and insomnia, as well as the new com plaint of bru xism. Following reinstitution of lithium carbonate on day seventy -seven, the patient's manic symptoms a nd his complai nts of bruxism resolved within three days . He was disc harged from the hospit al without recurrence of his ma nic symptoms on the one-hundred-and-fifth hospital day. Four months after discharge, he remains euthymic.
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This patient responded poorl y to neuroleptics and lith ium carbonate, but improved rapidly on a combination of carbam azepine a nd lithium carbonate. When an attempt was made to discontinue the lithium carbonat e, the patient develop ed a recurrence of his manic symptoms that resolved when it was reinstitu ted . Wh ile it remains impossible to excl ude a sponta neous remission , th e temporal relationship between treatment and symptom respon se appear s to support th e hypoth esis that this patient, while unrespon sive to lithium carbonate a nd carbam azepine alone, responded to a synergistic effect of the se drugs.
Elaboration of this proposed hypothesis awa its elucidati on of the methods of action of the individual agents. Although a number of hypotheses exist (2, 7, 8) , their incipient nature make speculation about the mechanism of ac tio n of these agents' a ppa rent synergism premature.
While thi s and other case reports suggest the usefulness of a com bination of lithi um carbonate and carbamazepine in otherwise tre atment-resist an t ma nic patients, its role as a treatment modality in affective disorders, including its poten tial risks (6), remain uncertainties th at merit further study.
